Bioactivity:

1. Potengriffioside A shows anticarcinogenic activity. 2. Potengriffioside A shows hepatoprotective activity. 3. Potengriffioside A shows antioxidant and anti-inflammatory activity, can inhibit neuroinflammation in neurodegenerative disorders. 4. Potengriffioside A has anti-diabetic effect, are at least partially mediated through inhibitory effects on carbohydrate digestion and glucose uptake in the gastrointestinal tract. 5. Potengriffioside A and gnaphaliin are antioxidants against in vitro Cu(2+)-induced LDL oxidation in the same order of magnitude compared to that of the reference drug, probucol. 6. Potengriffioside A enhances fatty acid oxidation via the enhancement adiponectin signaling associated with the activation of both AMP-activated protein kinase and peroxisome proliferator-activated receptor _ and ameliorates obesity-induced metabolic disorders.

CAS nr:

20316-62-5

Purity:

98%

Molecular Weight:

594,52

SMILES:

O[C@@H]1[C@@H](COC(=O)\C=C\c2ccc(O)cc2)O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)-c2ccc(O)cc2)[C@H](O)[C@H]1O

Formula:

C30H26O13

Pathway:

oxidation-reduction

Target:

Antioxidant